Here’s looking at you, kid.
Pfizer has begun administering its COVID-19 vaccine to children ages 5 to 11 years in phase 1 trials analogous to those done in older populations. | Park, TIME 2021
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Pfizer has begun administering its COVID-19 vaccine to children ages 5 to 11 years in phase 1 trials analogous to those done in older populations. | Park, TIME 2021
Comments
Post a Comment